NCT07112690View on ClinicalTrials.gov

Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 2, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Localized Anal CarcinomaLocalized Anal Margin CarcinomaStage 0 Anal Cancer AJCC v8Stage I Anal Cancer AJCC v8Stage II Anal Cancer AJCC v8Stage IIIB Anal Cancer AJCC v8
Interventions
OTHER

Electronic Health Record Review

Ancillary studies

PROCEDURE

Fluoroscopy

Undergo fluoroscopy

PROCEDURE

Ganglion Impar Neurolysis

Undergo ganglion impar neurolysis

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (2)

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

Grady Health System, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER

NCT07112690 - Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment | Biotech Hunter | Biotech Hunter